Laparen Tablet 250 mg contains Lapatinib, an oral anticancer medication used primarily for the treatment of HER2-positive breast cancer. Lapatinib is a tyrosine kinase inhibitor that works by targeting specific proteins involved in the growth and proliferation of cancer cells. By blocking these proteins, Lapatinib slows down tumor growth and helps control the progression of cancer.

Laparen Tablet 250 mg is commonly used in combination with other therapies, such as capecitabine or letrozole, to enhance treatment effectiveness. It is particularly indicated for patients whose tumors overexpress the HER2 (human epidermal growth factor receptor 2) protein, a condition associated with aggressive breast cancer.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Indications

Laparen Tablet 250 mg is indicated for:

• HER2-positive metastatic breast cancer – In combination with capecitabine for patients who have received prior treatments including anthracyclines, taxanes, and trastuzumab.

• Advanced or metastatic breast cancer – In combination with letrozole for postmenopausal women with hormone receptor-positive disease.

• Targeted therapy for HER2-positive tumors – When standard chemotherapy alone is insufficient.

Mechanism of Action

Lapatinib works by inhibiting tyrosine kinase enzymes associated with HER2 and EGFR (epidermal growth factor receptor). Its mechanism includes:

• Blocking HER2 and EGFR signaling pathways, which are critical for cancer cell proliferation

• Inducing apoptosis (programmed cell death) in cancer cells

• Reducing tumor growth and spread, helping control the progression of breast cancer

By specifically targeting these receptors, Lapatinib selectively inhibits tumor cells while minimizing effects on normal cells compared to conventional chemotherapy.

Dosage and Administration

• The dosage of Laparen Tablet 250 mg is determined by a healthcare professional based on the patient’s condition, body surface area, and combination therapy.

• Typically taken orally once daily at the same time each day, with or without food.

• Tablets should be swallowed whole with water, and the treatment schedule should be strictly followed to maintain effectiveness.

• Regular monitoring, including liver function tests and cardiac evaluation, is recommended during treatment.

Patients should avoid skipping doses and inform their doctor of any side effects experienced.

Precautions and Warnings

Before using Laparen Tablet, patients should consider:

• Liver impairment: Dose adjustments may be necessary in patients with liver dysfunction.

• Heart conditions: Monitor for potential decreases in heart function, particularly in patients with pre-existing cardiac issues.

• Pregnancy and breastfeeding: Lapatinib may harm the fetus and should not be used during pregnancy unless clearly needed.

• Drug interactions: Inform the doctor about all medications, supplements, and herbal products being used, as Lapatinib may interact with other drugs.

Patients must be closely monitored by oncologists during treatment.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Side Effects

Common side effects include:

• Diarrhea or nausea

• Fatigue or weakness

• Rash or skin reactions

• Liver enzyme elevation

• Loss of appetite

Serious side effects may include heart problems, severe liver toxicity, or severe diarrhea, requiring immediate medical attention.

Storage

Store Laparen Tablet 250 mg in a cool, dry place below 25°C, protected from light and moisture. Keep the medication out of reach of children.

Conclusion

Laparen Tablet 250 mg by SK Pharma is an effective targeted therapy for HER2-positive breast cancer, slowing tumor growth and improving outcomes when used alone or in combination with other anticancer drugs. Its tyrosine kinase inhibitory action provides focused treatment for aggressive breast cancer while minimizing effects on healthy cells. Careful adherence to dosage and regular monitoring ensures maximum effectiveness and patient safety.